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5PROLOGUE
ABSTR ACT
Background
In the 1990 s´, studies of paediatric intensive care around the world had shown better out-
come for children treated in PICUs compared to adult ICUs (AICU). In Sweden no nation-
wide data on children needing ICU care was present. 
Aim/Methods 
To quantify the Swedish need for and outcome of intensive care for children, a retrospec-
tive multicenter cohort study was set up to include all children admitted to intensive care in 
from March 1998 to March 2001. The cohort was monitored for five years and survival data 
analyzed. (Study I). When analyzing the data, it was obvious that PIM2 score and a more ex-
tended data set to study factors involved in long-term mortality post PICU care was needed. 
A new three-year cohort was formed, this time with only PICU admissions from January 1, 
2008 to December 31, 2010 (Study II). During the time of the study PIM2 score was not re-
ported from AICUs. 
Arterial blood gas (ABG) is one among several variables included into the PIM2 score. 
We felt that to minimize unnecessary trauma, the routine use of ABG was unwarranted un-
less clinically indicated or for certain groups of children. We therefore studied a subset of 
the cohort to determine how PIM2 score predictability was influenced with or without ABG 
(Study III). 
It was noted that some of the children who died in the years after discharge, did so out-
side the PICU (Study II). We therefore performed an additional study of the 268 children 
whom died in the latter cohort to determine if limitation of medical treatment (LOMT) was 
the factor opposing PICU readmission for these children when turning fatally ill (Study IV). 
Results/Conclusions
We found that the outcome of intensive care for Swedish children was on par with interna-
tional published data and 56% of the paediatric intensive care admissions were to AICUs. A 
20-fold increased risk of death five years post PICU discharge was also found for the cohort 
(Study I). In the following cohort we found that having multiple admission (MADM) com-
pared to single admissions (SADM) and/or a complex chronic conditions (CCC) significant-
ly impaired the long-term outcome for five out of the seven different admission diagnosis 
groups (Study II). We also found that since Study I there was an increase in transfer from 
AICU to PICU from 65 to at least 278 children. In Study III we could show that the PIM2 
score only becomes more accurate (although not significantly) if ABG is taken for the admis-
sion diagnostic group respiratory. In Study IV we in detail studied the 268 children that died 
in the cohort and could show that 123 (46%) died outside PICU. At the time of death 75% of 
them had a LOMT in place limiting readmission to PICU. Of the children not readmitted to 
PICU, 75% also had a CCC and 60% were males.
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1  INTRODUCTION
At the out start of this thesis Sweden had three dedicated PICUs. Paediatric surgery and 
medicine were thought to have good outcome in par with the rest of the world. However 
national outcome data regarding PICU care and figures on demand of intensive care for 
children in Sweden was scarce. North America, Europe and Australia called for central-
ization of PICU care but the overall situation in Swedish was unknown. 
The tabloid medical perspective
September 13, 1961 the Swedish tabloid “Expressen” reported on the 6th English paedi-
atric surgeons congress in Stockholm. The Swedish surgeons and anesthetists had been 
very progressive and as an homage the British congress was placed in Sweden. The Swed-
ish anesthetists presented their progressive view on ventilating the newborn infants, but 
the British surgeons were sceptic. At the same time a machine for mechanical ventila-
tion was just being finished at the Great Ormond Street children’s hospital for periopera-
tive “artificial ventilation”. This novel approach of mechanical ventilation was suddenly 
put in a very dramatic context when the Swedish anaesthetist, Hans Feychting urgently 
needed to leave the congress and run to Kronprinsessan Lovisas hospital, the Paediatric 
hospital where he was running a newly opened PICU.
At the hospita, with mechanical ventilation, he had to assist a newborn. The British 
surgeons tag along (and a TV team from Swedish news “Aktuellt”) and watch as a 1700g 
child was being ventilated and treated for “hyaline membrane disease”. 
11
In those days just ventilating a sick child was considered as a very advanced and 
spectacular medical treatment. Subsequently the whole incident made the headlines of 
the tabloid press. Unfortunately, the child eventually died, which of course also was re-
ported in “Expressen”.
Rapid intensive care development
After the second world war the surgical, technical and anaesthesia development had been 
rapid and there was an increasing demand for care of patients in the perioperative period 
as well as during the outbreaks of polio.
The Danish anesthesiologist Björn Ibsen organized the care of ventilated polio pa-
tients during the ongoing polio epidemic in Copenhagen. He is often considered to be the 
father of modern intensive care since he started to ventilate the patients with positive pres-
sure using a tracheostomy instead of employing a negative pressure of an ’iron-lung’.1,2 
Ibsen set up his ICU in 1953. He was managing the polio outbreak in Denmark at the same 
time as Sweden’s first ICU was formed in Borås 1952 by Åke Bauer who made an immense 
The Engström ventilator, Kronprinsessan Lovisas Hospital.
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pioneering effort.3 He held a speech during the Swedish anesthetists yearly meeting in 
Borås 1953 with the title; “One year’s experience of postoperative- and Intensive care”. 
Scandinavian anaesthetists had been very early in adapting the concept of centralizing 
the sickest patients and the network of the Scandinavian Society of Anesthesiologists 
played an important role in the sharing of new technology and experience of different 
treatments.
The intensive care of children
Medical developments starting in the 1920 s´ with specific focus on artificial ventilation, 
thermoregulation and feeding eventually led to the development of neonatal intensive 
care units (NICU) with focus on the premature babies.4 The first PICUs cared for all chil-
dren that were severely sick and specifically needed ventilation, from premature babies 
to post-operative care of adolescents. Although there still can be some overlap found, the 
NICUs and PICUs are now very different entities. 
The first PICU in the world was set up in Gothenburg 1955 by Dr Göran Haglund 
and the experiences of the first 300 days were reported in Helsinki at the 4th congress of 
the Scandinavian Society of Anesthesiologists.5 Swedish anesthetists were pushing the 
envelope for different treatments and in 1958 Haglund published the first case report on 
successful mechanical ventilation of a patient with the so called IRDS/hyaline membrane 
disease.6 Like many anaesthetist at that time Göran Haglund, Åke Bauer and Bjørn Aage 
Ibsen were all trained in the US and had been influenced by the ideas that specialized units 
for the sickest patients was the future. Inspired by his colleagues, in 1961 Hans Feychting 
started the second Paediatric Intensive care unit in the world at Kronprinsessan Lovisas 
hospital. The PICU at Kronprinsessan Lovisas hospital was simply called the emergency 
ward, “akutavdelningen”. 
In the following decade ICUs and PICUs were organized in Europe, Australia and 
north America7-9 and a remarkable development of intensive care was to follow. 
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2  BACKGROUND
Differences in paediatric and adult physiology  
and reason for ICU admission
Adult and paediatric physiology differs in many important aspects. Due to the much 
smaller diameter of the bronchial tree, airway resistance obviously can be very high in 
the newborns compared to adults.10 The undeveloped diaphragm and a less rigid tho-
rax composition also leaves the newborn vulnerable to ventilatory challenges.11 Oxy-
gen consumption per kg bodyweight is significantly higher and circulatory physiology 
is different than adults12-15 The cause of ICU admission is also different for children and 
adults. In Sweden cardiovascular disease in the most common reason for PICU admis-
sion whereas injury is the most common in children admitted to AICUs.16 The adult 
ICU-patients have a diagnostic panorama dominated by the influence of the ageing phys-
iology, especially the circulation, and infections17 Specialized units with specific knowl-
edge of paediatric circumstances was apparently necessary to improve quality of care for 
the newborns and children.
Artificial ventilation
The concept of positive pressure ventilation with the use of a tracheostomy was first pub-
lished in 1543 by Andreas Vesalius.18 To quote: “But that life may be restored to the ani-
mal, an opening must be attempted in the trunk of the trachea, into which a tube of reed 
or cane should be put; you will then blow into this, so that the lung may rise again and 
take air”.
   This was then forgotten until Galen further explored the interaction between ven-
tilation and circulation.19  The anaesthesia of patients that needed surgery have come in 
different pharmacological ways since first described in China in the Book of Master Han 
Fei (c. 250 BC).20 Patients needed to relay on spontaneous breathing to survive and the 
concept of a controlled airway during Anaesthesia was first reported in 1871 by German 
surgeon Friedrich Trendelenburg21-24 who used tracheostomy for general Anaesthesia. 
The alternative way through orotracheal intubation was reported in 1880 by Scottish sur-
geon William Macewen25-27 The intubation procedure as a reliable alternative for con-
trolling the airway during surgery was finally reported in 1913 by Chevalier Jackson.28 
He introduced a new concept with a light-source at the distal tip of a new long blade and 
made it possible to intubate safely. In 1913, Henry H. Janeway put a batteries in the han-
dle, made a central notch in the blade and put a slight curved tip on the blade.29  These 
improvements made the intubation technique very popular and together with trache-
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ostomy and a development from steel cannulas to plastic and silicone tubes, eventually 
patients could be positive pressure ventilated longer and treated for in the intensive care 
setting.
In the late 19 c´entury the negative pressure ventilators, so called iron lungs were de-
veloped. They caused a lot of practical problems since the patients were enclosed and the 
gas exchange was sub-optimal. The Polio epidemics of the 1950 s´ with a high demand for 
ventilators made the ventilator market soar. In the beginning these new ventilators were 
not adapted to the paediatric patient and adjustments had to be made. 
A typical sign of the times was when Dr Göran Haglund and his colleague Åke 
Waldinger, now with a lot of experience from ventilating polio-patients in Gothenburg, 
became two among many pioneers who tried to find ways to improve the ventilatory care 
in children. They developed the Gothia ventilator 1954 and presented it in the mid 50 s´.30 
It was still running at least 20 years later.31 Gothia was very advanced with humidified 
and filtered air, it could be hand-cranked and if the gas supply stopped, room air could 
be used. It could be place at the end of the patient bed and transporting the patient was 
possible.
 
The Gothia ventilator by Göran Haglund and Åke Waldinger: Nordisk Medicin 1955: 53: 804
Another example of how physicians tried to share knowledge is the published recipe 
on how the Siemens 900b ventilator could be tweaked with some new parts (and some-
times duck-tape) to achieve a machine suitable for ventilation of newborn infants.32
The sharing of medical development and experience at the beginning of the 50 s´ 
were mainly through the network of Scandinavian Society of Anesthesiologists and the 
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yearly rapport called the “proceedings of the yearly congress” published the latest news. 
The scientific paper Acta Anaesthesiologica Scandinavica was established in 1957 and is 
the official publication of the now called Scandinavian Society of Anaesthesiology and 
Intensive Care.
Outcome
There are some published and anecdotal data on outcome for subgroups of paediatric pa-
tients in need of PICU care from the -50 s´ and -60 s´. For example, before 1952 ventilated 
polio patients had a three-week polio respiratory mortality above 80% in Scandinavia. 
It dropped to 40% in Copenhagen 1952 and 30% in Stockholm 1953. From 1956 to 1961 
there were no deaths within two years after PICU care reported among patients with po-
lio that needed ventilator treatment.33 Parallel to progress of ventilatory treatment and 
outcome there were some reports on children with sepsis and septic shock. Mortality re-
ported from Minnesota Medical center between 1958 and 1966 for children <16 y of age 
with gram-negative sepsis, was 60% for medical patients and 40% for surgical catego-
ries.34 For septic children with septic shock the mortality rate was 98%! Since then the 
mortality rate have decreased dramatically thanks to modern intensive care.35
In order to measure and compare outcome, the need for a systematic approach was 
obvious and the first published attempt to use as scoring system to evaluate PICU mor-
tality was published in 1982, the therapeutic intervention scoring system (TISS).36 TISS 
was used to evaluate the outcome of 461 North American PICU patients. The mortality 
rate was 18%, dominated by admission diagnosis trauma 29%, cardiac 25% and malig-
nancy 22%. Sepsis only had 6% mortality rate, but then again diagnostic grouping was 
defined as “population characteristics” and still needed some attention to be comparable 
between cohorts. In this study the TISS score could not differentiate between survivors 
and non-survivors. Additional studies with TISS and the Clinical Classifications System 
(CCS) could demonstrate an association with outcome. Higher scores were associated 
with higher mortality risk.37
Pediatric Risk of Mortality Score, PRISM
In North America the TISS, CCS and eventually the developed Physiology Stabili-
ty Index (PSI) were adopted in the evaluation of the PICU population.38,39 The PSI as-
sessed 34 variables from seven organ systems, with scoring regarding the degree of 
abnormality. PSI was further developed into PRISM and PRISM III with 17 vari-
ables (published in 1996) that became a well-established standard mortality predic-
tion model for PICU care,40,41 The same cohort of 11,165 children used for PRISM 
III was later utilized to develop the Pediatric risk of mortality III-Acute Physiolo-
gy Score (PRISM III-APS).42 PRISM III-APS then contained 21 physiological vari-
ables that better could detect smaller changes in physiologic status. Since the PRISM 
was based on the most abnormal physiologic values during the first 24h, a poor initial 
PICU treatment would have high scores as a result. A worse outcome for a unit with 
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poor initial treatment could incorrectly be attributed to having sicker patients. This 
aspect and the fact that in the mid 90 s´ a license fee had to be paid for using the PRISM 
made it less popular and stimulated other scoring systems to be developed elsewhere.
The Paediatric index of mortality score, PIM
In an attempt to develop a mortality prediction model less sensitive to poor initial patient 
management a mortality prediction model based on UK and Australian cohort data was 
developed out of initially eight “explanatory variables” collected at the time of admission. 
It was named the Paediatric Index of Mortality (PIM). This logistic regression model was 
based on cohort data from 5,695 PICU patients and was published in 1997.43 It was fur-
ther developed into the very popular PIM244 published in 2003 based on 20,787 patients 
from New Zealand, Australia and UK. PIM2 rendered worldwide recognition. The latest 
version of PIM, the PIM345 was published in 2013 and is based on 53,112 PICU patients 
from 60 ICUs in Ireland, UK, Australia and New Zealand admitted in 2010-2011. In Swe-
den the PIM3 has been adopted by the Swedish intensive care registry (SIR) since 2016 
and many PIM3 calculators can be found online.
  PIM3 is calculated as follows:  
PIM3 score = (3.8233 × pupillary reaction) + (−0.5378 × elective admission) + 
(0.9763 × mechanical ventilation) + (0.0671 × [absolute {base excess}]) +  
(−0.0431 × SBP) + (0.1716 × [SBP2/1,000]) + (0.4214 × [{FiO2 × 100}/PaO2]) − 
(1.2246 × bypass cardiac procedure) − (0.8762 × non-bypass cardiac procedure) − 
(1.5164 × noncardiac procedure) + (1.6225 × very high-risk diagnosis) +  
(1.0725 × high-risk diagnosis) − (2.1766 × low-risk diagnosis) − 1.7928.
  Probability of death = exp (PIM3 score)/[1 + exp (PIM3 score)]. 
Since the standardized mortality ratio* (SMR) has drifted due to medical develop-
ment and most countries have a SMR below 1, different countries “calibrate” their PIM 
score so the country PIM scores fit a SMR of 1. In the figuer below from the Swedish in-
tensive care registry you can see PIM2 before (left) and after calibration (right) 2012. The 
coefficient – 4,8841 (for PIM2) in the end of the calculation, is changed and all the other 
coefficints multiplied with the same factor. The goal to have a so called Cox s´lope 1,00 
after calibration. 
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* Standardized mortality ratio, (SMR) is: observed mortality / expected mortality (calculated from the from the PIM2 score)
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If the same version or “calibration” of the PIM score formula is used, you can com-
pare outcome between countries and PICU wards. One need to keep this in mind when 
comparing PIM score levels between countries (or wards).
The Australian and New Zealand Paediatric  
Intensive Care (ANZPIC) Registry
During the 80 s´ and 90 s´ a structured approach to evaluation of PICU outcome had de-
veloped. Parallel to the scoring systems, groups were formed to support intensive care 
units. One of these groups were The Australian and New Zealand Paediatric Intensive 
Care (ANZPIC) Registry.46  It was established by the Australian and New Zealand Inten-
sive Care Society (ANZICS) Paediatric Study Group in 1997 with three aims:
• To describe paediatric intensive care practices and outcomes in Australia and New 
Zealand.
• To provide contributing units with efficacy and efficiency reports that compare per-
formance in their units against national and international standards.
• To facilitate research in paediatric intensive care.
One of the ANZPIC registry utilities is the admission diagnostic codes. This tool is 
used when reporting admitted patients (in Australia and New Zealand) to the registry 
but can also be used to stratify cohort data to elucidate reason for PICU admission. In the 
studies presented in this thesis both cohorts were stratified according to these admission 
diagnostic codes.
Outcome and centralisation 
In the -90s´ , the technical development of ventilators and general ICU care had given 
most AICUs the possibility to not only treat adults but also children in ventilatory dis-
tress with ventilators. Now, without the need to make adjustments to the ventilator con-
struction to suit the paediatric patients. The possibility to measure ICU mortality and 
SMR, since mortality prediction tools were readily available, together with development 
of patient transport systems, stressed the fact that big differences in outcome between 
non tertial hospitals and specialized units was no longer acceptable and could be over-
come by transfer of patients to specialised units.47-50
Both the American College of Critical Care Medicine and the Society of Critical 
Care Medicine were obligated to endorse the principal of regionalisation of PICU care. 
Although the UK had been trying to centralise PICU care the situation was still frag-
mented.
An epic study was published 1997 in the Lancet by Gael Pearson and Frank Shann51 
were ICU mortality rate was compared between The Trent Health Authority, UK, and 
the state of Victoria, Australia. The regions had comparable populations with slightly 
over four million inhabitants but in Victoria the PICU care was centralized and in Trent 
it was scattered.
The study showed, both with PRISM and PIM score, a twofold, 2.07 odds ratio for 
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death of children in Trent relative to Victoria. In Trent only the PICU at the Birmingham 
Children’s Hospital showed less than expected deaths. The study reverberated through 
the UK and in Sweden a discussion started on where to treat children in need of inten-
sive care and if to centralize, was there a sufficient number of beds? The stage was set for 
a Swedish study.
The current ICU situation in Sweden.
During the time of the studies presented in this thesis, there were three specialized pae-
diatric intensive care units, PICUs in Sweden. They were (and still are) located in Stock-
holm, Lund and Gothenburg. They care for children no younger than 32 gestational 
weeks and up to 16 years of age (patients with medical conditions can be up to 18 years 
of age). Today, a fourth PICU recourse is located together with the AICU of Uppsala Ak-
ademiska Sjukhus. Adult Intensive care units in Sweden were 78 at the time of the first 
study but have since then through reorganization become 80. There are specialized ICUs; 
eight thoracic (THIVA)-, five neuro (NIVA)-, two infections (infektions-IVA)-, two burn 
(BrIVA)- and one ECMO-ICU. A total of 516 available ICU-beds were reported in 2017 
(ref SIR yearly report 2017).17
Limitation of medical treatment, LOMT
All patients might not benefit from every possible medical treatment or strategy. A com-
monly used strategy in Sweden is to adjust the level of treatment according to the clini-
cal and ethical situation. In contrast to adults, a child mostly cannot give voice to their 
own wishes and decisions, these discussions therefore mostly are performed together 
with the parents. To reach a decision concerning the best level of care for a specific pa-
tient mostly requires a structured discussion among colleagues and parents. Once a deci-
sion is formed it will be noted into the patients’ medical journal. In Sweden, in contrast 
to many other countries, it is the doctor treating the patient (in cooperation with other 
involved specialties) that makes the final decision concerning the level of care. To limit, 
withdraw or withhold medical treatment comes with different names in different coun-
tries and cultures52 In Sweden, the commonly used term is “limitation of medical treat-
ment”, LOMT. To be legally valid, and not lost in staff shift reports, there is a standard-
ized document in the patient journal where responsible clinician concludes the situation 
of the patient, the decision(s) made, specialists involved in the discussion, time and date. 
Any possible treatment strategy, modality and level can here be decided upon. Previ-
ously, the frequency of LOMT has not been known among children who die the coming 
years after PICU discharge.  
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3  AIMS
The overall objective of this thesis was to determine the need for Swedish pediatric in-
tensive care and to deepen field-specific knowledge regarding the children admitted to 
PICU/ICU care by describing effects on short-term and long-term outcomes. 
 Specific aims were:
 1. To determine the total number of children yearly admitted to ICU care in  
 Sweden. 
 2.  To describe PICU mortality in Sweden.
 3. To describe Long term mortality (5-year). 
 4.  To compare Swedish PICU outcome with published data through PIM2.  
 5.  To evaluate factors involved in long-term outcome. 
 6.  To evaluate the need for arterial blood gas in the PIM2 calculation. 
 7. To determine if limitations of medical treatment (LOMT) limited readmission  
 for children not readmitted to PICU when becoming terminally ill. 
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4  METHODS
Paper I
Study design 
A national, closed cohort was formed of all paediatric patients between six months and 16 
years of age admitted either to one of the three PICUs or to an adult ICU in Sweden between 
March 15, 1998 and March 14, 2001. A second data collection of  the same parameters 
was made from all PICUs including all infants 1 to 6 months of age admitted to a PICU 
during the same time. For practical reasons data on that age group were not retrieved 
from the adult ICUs. Data on gender, age, time of admission and discharge, rout of ad-
mission was collected. 
The main ICD-10 diagnosis stating the reason for index PICU admission was used to 
assign each patient to one of seven main admission diagnostic groups. These groups were 
compiled applying the uniform diagnostic coding system used in the Australia and New 
Zealand Paediatric Intensive Care (ANZPIC) Registry.46 All patients had one or multiple 
valid ICD-10 diagnoses registered during their PICU admission. 
Diagnostic groups
The diagnostic groups consisted of Injury (Inj), Neurological (Neuro), Postoperative 
(Post Op), Cardiovascular (CVS), Gastrointestinal/Renal (GI), Respiratory (Resp), and 
Miscellaneous (Misc). The Misc group included sepsis, post-cardiac arrest, malignancies, 
endocrine disorders, and allergic reactions in accordance with the recommendations for 
the ANZPIC registry. Adjustments had to be made for the retrospective nature of the 
coding; for example, the ANZPIC registry group “Postoperative Cardiovascular” had to 
be included in the CVS group as it was not possible to differentiate post-operative ad-
missions from other admissions with CVS diagnoses. The diagnoses Postoperative ENT/
Thoracic, Postoperative Neuro, and Postoperative Other were all included in one group 
termed Postoperative (Post Op). 
ICU was defined as an ICU with resources to treat patients with intubation and me-
chanical ventilation for more than 24 h, a definition used previously in ICU epidemio-
logical studies.53 In this study, exposure was defined as admittance to intensive care and 
outcome defined as survival up to 5 years post the last registered ICU admission during 
the study period. 
Survival calculation 
Vital statistics for each patient (dead or alive up to 5 years after inclusion) were obtained 
from the File of National Registration 6 months after the study endpoint of 14 March 
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2006 to allow for the file to be accurately updated. To compare the cohort with the back-
ground natural mortality, a comparison of vital data for all children living in Sweden not 
exposed to ICU care and of the same ages and for the same time period was also made. 
Paper II 
Study design 
A new national, prospective, closed cohort was set up between January 1, 2008 and De-
cember 31, 2010. All pediatric patients up to 16 years of age with Swedish 10-digit per-
sonal identity numbers admitted to one of the three Swedish PICUs were included in the 
study. During the study period, specialized PICU care was carried out at three locations 
in Sweden. These included The University Hospital of Lund, The Queen Silvia Children’s 
Hospital at Sahlgrenska University Hospital of Gothenburg, and the PICU and ECMO 
Centre’s of Astrid Lindgrens Children’s Hospital at Karolinska University Hospital in 
Stockholm. 
The first noted admission during the study was defined as the index admission. Sur-
vival within the cohort after PICU index admission was checked through the File of Na-
tional Registration 54 on January 1, 2012, resulting in an assessment after at least one but 
up to four years post index admission. For each patient, the following data were collect-
ed: personal identity number, PICU admission diagnosis (ICD-10), PIM2, and time and 
source of admission and discharge. 
Patient groups
Similar to our first study (Paper I) depending on admission diagnosis, every patient was 
assigned to one of seven admission diagnostic groups. The diagnostic groups consisted of 
Injury (Inj), Neurological (Neuro), Postoperative (Post Op), Cardiovascular (CVS), Gas-
trointestinal/Renal (GI), Respiratory (Resp), and Miscellaneous (Misc).16. 
Patients were then assigned into two groups depending on the presence of a single 
admission (SADM) or multiple admissions (MADM) to the PICU. Patients with more 
than one admission were assigned to early or late readmission groups in conjunction 
with earlier studies.55,56 Early readmission was defined as being readmitted within 48 
hours of discharge from PICU, while late readmission was defined as being readmitted 
after 48 hours post PICU discharge. 
In accordance with the praxis of European Medicines Agency (EMA) for children,57 
five different age groups were also formed: 0–2 days, 3–28 days, >28 days–2 years, >2–12 
years, and >12–16 years. The age-group affiliation for each patient was decided by patient 
age on index admission. 
Complex Chronic Conditions
When finalizing the study, we were made aware of the possible impact of complex chron-
ic conditions (CCC) in the PICU population. We therefore added data regarding the 
presence of a CCC and CCC subcategories into the dataset. The updated list of complex 
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chronic conditions version 2 (CCCv2) with 10 subcategories was used. No patient was 
assigned to the 11th group, “Premature and Neonatal.” Complex chronic conditions 
(CCCs) were initially defined by Feudtner,58 further explored in the PICU population by 
Edwards59 and updated to the CCCv2 by Feudtner.60 Combining the presence of a CCC 
with sorting by reason for PICU admission according to the ANZPIC system, allowed us 
to describe the data related to underlying chronic morbidity and permitted us to indicate 
which acute event made PICU care necessary. 
Data collection and validation 
For each patient, the following data were collected: personal identity number, PICU ad-
mission diagnosis (ICD-10), PIM2, and time and source of admission and discharge. All 
admissions were checked for the presence of a CCC and a CCC subcategory. If more than 
one CCC was present, the first noted was used for CCC subcategory classification. The 
PIM score was verified through an extensive check of data validity by two experienced 
pediatric intensivists. All admissions were checked for accuracy regarding the time of ad-
mission and discharge. After extensive verification of the admission data, 449 temporary 
so-called “reserve numbers” could be converted to valid personal identity numbers, and 
51 non-Swedish citizens were identified and excluded from the study. The personal iden-
tity numbers of the patients in the cohort were sent to the Swedish File of National Reg-
istration54 to obtain survival data. The Swedish File of National Registration keeps a gov-
ernmental-controlled registry of all Swedish citizens, including date of birth and date of 
death. PICU mortality risk and standardized mortality risk (SMR) were calculated using 
the PIM2 (2003) model.2 The Swedish Intensive Care Registry (SIR)17 has continuously 
collected admission data and subsequent PIM scores for all Swedish PICU patients since 
2007. Because this process was under implementation during the time of this study, data 
for our investigation were collected directly from each PICU. 
Statistics 
The PICU mortality for each diagnostic, age, or admission group was calculated. Mor-
tality outside the PICU was calculated for the SADM and MADM groups respectively. 
Long-term survival was expressed as Kaplan-Meier (KM) curves for the single or multi-
ple admission groups and, for the four groups, single or multiple admission with or with-
out a CCC present. Censoring was carried out by January 1, 2012 or at the time of death. 
Differences between curves and the hazard ratio were examined by using both Log-rank 
(Mantel-Cox) and Gehan- Breslow-Wilcoxon tests. Likewise, differences between KM 
curves of single or multiple admissions for the diagnostic subgroups were evaluated. Dif-
ferences were considered statistically significant when p<0.05; for multi-group compari-
son of the curves of SADM and MADM with or without CCC, p<0.0083 was considered 
statistically significant after Bonferroni correction (K = 6). Mortality rates (MR) for the 
different admission diagnostic groups were calculated (total number of deaths during 
time of follow-up divided by total accumulated person-time during follow-up), expressed 
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as deaths per year of follow-up time. Patient follow-up time was accumulated from start 
of index admission to censoring. Mortality rate ratios (MRR) between admission group 
mortality rates were calculated (MR SADM / MR MADM). 
The PICU follow-up data, KM curves, MR, and MRR have been illustrated. Descrip-
tive statistics, curves, and survival calculations were carried out using MS Excel (Mi-
crosoft Corporation, Redmond, Washington, USA) and GraphPad prism 5.4 (GraphPad 
Software Inc. San Diego, USA). Data are given as median values and inter quartile range 
(IQR). 
Paper III
Study design 
Due to data formative reasons in this study only a subset of data from the cohort gathered 
in paper II could be included, namely the data from patients consecutively admitted to 
the PICU in the Queen Silvia Children’s Hospital (DSBUS) from January 1st 2008 to De-
cember 31st 2010. The PICU is one of two centers in Sweden for paediatric cardiac surgery 
and has a case mix with approximately 50% cardiac cases. 
As in paper I and II all admissions were classified into seven different diagnostic 
groups in accordance with the Australian New Zeeland Paediatric Intensive Care, (ANZ-
PIC) registry (4). This time a separate group called non-Respiratory was formed contain-
ing all the groups but the Respiratory patients.
The impact of the PaO2/FiO2 ratio on the PIM2 score and its derived probability 
was estimated in patients with available PaO2 data at admission by comparing the PIM2 
score estimated with and without PaO2 data. 
The difference in predictability between the non-respiratory and respiratory groups 
was tested without arterial blood gas data included in the PIM2 calculation. 
Standardized mortality ratio (SMR) for the study group and the diagnostic sub-
groups respiratory and non-respiratory was also explored and presented. The groups 
with and without arterial blood gas data present were also compared.
Statistics
Tests for correlation between PIM2 scores estimated with and without arterial blood gas 
data and probability estimated with and without arterial blood gas data were performed 
by the Spearman rank correlation. 
Bias, expressed as percentage mean prediction error (MPE%) and precision, ex-
pressed as percentage root mean square prediction error (RMSE%), were calculated as 
outlined by Sheiner and Beal.61 The Mann-Whitney U-test was used to analyse differenc-
es between two unrelated observations. 
The variance ratio test was used for the comparison of the variability of data in two 
populations, for example in the non-respiratory and respiratory groups. Classified data 
from two independent populations were compared by the Fischer exact test. 
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Standardised mortality ratio (SMR) and its 95% confidence intervals were calculat-
ed as given by Liddell (62). Data are presented as median values and inter quartile range 
(IQR) unless otherwise stated.Statistics were evaluated by MS Excel (Microsoft Corpora-
tion, Redmond, Washington USA) and Graph Pad Instat 3.10 (Graph Pad Software inc. 
San Diego, USA). All reported p-values were from two-sided tests and considered statis-
tically significant if p <0.05.
Paper IV
From the cohort formed and studied in paper-II a sub-analysis was made in the 268 chil-
dren that died in the years after PICU discharge. For these children medical records were 
checked for presence of LOMT decisions and statements regarding yes or no to PICU re-
admission. The children were grouped according to place of death; after being readmit-
ted to a PICU (PICU group), or in Hospital (Hospital group) or at home (Home group). 
In the PICU group presence of any sort of LOMT in the records was noted as presence of 
a LOMT. For the Hospital and Home groups LOMT was noted if containing no readmis-
sion to PICU. Gender, age, survival time, admission diagnostic group and presence of a 
chronic complex condition (CCC)21, 22 were identified.
Ethical considerations
The Central Ethical Review Board at the Karolinska Institute approved this nationwide 
study after consulting with the regional boards at Gothenburg and Lund [Dnr 02-483] 
(Paper I). For the second cohort, (paper II-IV) extended ethical approvals were sought 
and subsequently granted [Dnr 2007/1073-32, Dnr 2008/39-32, KI-Dnr 2009/1295-32. KI 
Dnr 2016 /2274-32].
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5  R ESULTS
Paper I
ICU admission, demographics and LOS 
Of the eligible ICUs, 70 (86%) participated. A total of 8063 admissions were recorded for 
the 3-year period by 6661 individual patients (Table 1).
 
Of these, 650 were infants between 1 and 6 months of age, with 926 admissions to PICU. 
The estimated loss of data were approximately 400 admissions (see ‘Methods’). Eight 
hundred seventy-two patients (13%) had two or more admissions during the period. Of 
the multiple admissions, 213 were re-admissions to the same ICU within 2 days and 165 
were transfers between ICUs in different hospitals. Sixty-five of the inter-hospital trans-
fers were from an adult ICU to a PICU. The rate of re-admission within 2 days was 2.7%, 
3.5% in PICU and 2.0% in adult ICU. The median LOS was 1 day, both for PICUs and 
adult ICUs (Table 1). Of all PICU admissions, 46% had a LOS of more than 1 day and 
FIgure 1A  AICU                                 Figure 1B PICU
Figure 1A and 1B  demonstrating % of different admission diagnostic groups for the AICU and 
PICU groups.
Table 1 Demographic data
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19% 43 days. The corresponding number for adult ICUs was roughly half, 23% and 8%, 
respectively. The median age was 6.1 years for all admissions. In PICU, the median age 
was 2.1 years for all patients and 4.8 if only patients older than 6 months were included; 
the corresponding age for adult ICU was 9.5 years. Of all the patients admitted to PICU, 
46% were females and 54% were males. In adult ICUs, 44% were females and 56% were 
males. The difference in diagnostic panorama Is presented in figure 1A and B. 
A clear difference could be seen in diagnostic panorama with the adult ICU having 
Injury and PICU having cardiovascular as the dominating admission diagnosis. All pa-
tients were followed-up for up to 5 years. A total of 366 patients had died, resulting in a 5- 
year mortality of 5.6%. The mortality during the last registered ICU admission was 2.1% 
(Table 1). Among these, we found 4.2% mortality (6/142) for re-admission and 4.4% mor-
tality (6/135) after transfer to the last registered admission. The all over mortality for the 
cohort in the fifth year after admission was still 0.28%, compared with the expected year-
ly mortality of 0.013% in a non-ICU-exposed comparable cohort of children. For the dif-
ferent diagnostic groups, the 5-year mortality and the immediate ICU mortality (in pa-
renthesis) were Injury 2.2% (1.0%), Miscellaneous 15.8% (6.0%), Respiratory 9.4% (2.4%), 
Neurological 8.3% (2.9%), CVS 6.5% (2.1%) and GI 5.6% (2.4%). For the post-operative 
patients, as a group, the 5-year mortality was 4.1% and the ICU mortality was 0.2%. The 
youngest patients had the highest mortality. For infants 0-6 months old the mortality 
was 9.4% (3.1%); in the age range of 6 months–1 year the mortality was 7.7% (3.6%), com-
pared with 5.1% (2.0%) for the other age groups together. The overall 5-year mortality in 
PICU was 7.3%, and the corresponding number for the adult ICU was 4.3%.
Paper II
Patient demographics
During the inclusion period of 36 months, 5,019 admissions were made by 3,688 individ-
uals with complete personal identity numbers. A majority of the patients, 79% (n=2,909) 
had only one PICU admission, SADM, while 21% (n=779) of the patients had two or 
more admissions, MADM. This yielding a total of 2,110 (42% of total admissions). The 
median length of stay (LOS) was 1.3 days (IQR 0.8–3.7 days), and 28.1% of all admis-
sions had a LOS of more than three days. Not surprisingly more admissions were made 
by males (56.8%) than females (43.2 %), and the same proportions of males (56.9%) and 
females (43.1 %) were seen among individuals admitted. There was a 5.3% loss to follow 
up since 196 admitted Swedish children had incomplete personal identity numbers or re-
serve numbers and could not be identified in the Swedish File of National Registration. 
Admission diagnostic and age groups
The overall distribution of diagnostic groups at admission was CVS 39%, Resp 20%, Misc 
14%, GI 10%, Neuro 10%, Inj 5%, and Post Op 2%. Groups Inj and Post Op combined in-
cluded only 279 admissions.
The median age among patients was 8.7 months. There were 304 admissions (n=288) 
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Fig 3. K-M curves for patients 
with single admissions (SADM) 
and multiple admissions 
(MADM) with or without a com-
plex chronic condition (CCC).
of patients between 0 and 2 days of age, 754 admissions (n=805) from over 2 days up to 
2 months of age and 2208 admissions (n=1195) from over 2 months up to 2 years of age. 
There were only 400 admissions (n=332) over 12 years of age. Age groups, LOS, and PICU 
mortality are presented in Table 8.
PICU mortality, SADM, MADM, and CCC survival
The PICU mortality for the cohort was 2.8 % (140 deaths in 5,019 admissions). In the di-
agnostic groups, the PICU mortality was as follows: Misc 8.9%, Neuro 4.5%, Resp 3.2%, 
GI 2.7%, CVS 2.1%, Inj 1.8%, and Post Op 0.0%. The group of SADM patients (n=2,909) 
had a PICU mortality of 3.0% (n=88), while the group with multiple admissions (n=779) 
had a mortality of 6.7% (n=52) on subsequent admissions. A significant difference was 
also seen in survival over time between single and multiple admissions groups, Fig 2. 
A CCC was present in 46.8% (1,728 of 3,688) of the patients. In the group of MADM 
patients with CCC, 16.2% (82 of 507) of the patients died, which represented 75.2% (n=90) 
of all the deaths in the MADM group. In the group of SADM with a CCC, 7.5% (92 of 
1,221) of the patients died, which represented 57.5% (n=160) of all deaths in the SADM 
group. The cumulative survival for SADM and MADM patient groups with or without a 
CCC is presented in Fig 3; p-values are provided in Table 2.
Fig 2. Cumulative survival for the 
single and multiple admission 
groups. 
Statistically significant differ-
ences between curves are as 
follows: Hazard Ratio 3.28; 95% CI 
2.43–4.44, Log-rank (Mantel-Cox) 
or Gehan-Breslow-Wilcoxon Test, 
both p<0.0001.
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Subgroup   Subgroup p-values  p-values                
   (Log-rank  (Gehan-Breslow- 
   (Mantel-Cox) Test) Wicoxon Test)
MADM + CCC vs MADM  Not CCC 0.0208 0.0166
MADM + CCC vs SADM + CCC <0.0001 <0.0001
MADM + CCC vs SADM   Not CCC <0.0001 <0.0001
MADM  Not CCC vs SADM + CCC 0.1674 0.2982
MADM  Not CCC vs SADM   Not CCC <0.0001 <0.0001
SADM + CCC vs SADM   Not CCC <0.0001 <0.0001
Values of p<0.0083 were considered statistically significant after Bonferroni correction (K=6). 
 
Table 2. p-values for comparison between patients with single (SADM) or multiple (MADM) 
admissions with or without a complex chronic condition (CCC). 
SADM, MADM and MR for admission diagnostic groups
The impact of SADM and MADM was explored in detail for the diagnostic groups. The 
results are presented in 4a and 4b. 
 
PICU mortality, mortality rate, and mortality rate ratio 
Total patient follow-up time during the study was 8,688 patient years, accumulated from 
the start of each index admission. Median follow-up time was 2.6 years (IQR 1.65–3.25) 
for patients with single admissions and 2.5 years (IQR 1.6–3.3) for patients with multiple 
admissions. The total mortality in the cohort during the time of the study was 268 indi-
viduals and corresponded to a MR of 0.023 in the single admission group and 0.062 in the 
multiple admissions group giving an MRR value of 2.69. MR and MRR for all diagnostic 
groups presented in Table 3.
Fig 3. Kaplan-Meier plots showing diagnostic group survival on single admission (a) and multi-
ple admissions (b). There was a difference (p<0.001) between single and multiple admissions in 
all of the diagnostic groups except Inj and Post Op. Neuro displayed a p=0.04. All p-values are 
presented in Table 9.
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Single admission 
ANZPIC 
Diagnostic group All groups CVS GI Injury Neuro Post op Resp Misc
Numbers of patients 2,909 1,087 279 209 312 70 518 434
PICU mortality n (%) 88 (3.0) 22 (2.0) 5 (1.8) 4 (1.9) 13 (4.2) 0 (0.0) 11 (2.1) 33 (7.6)
Mortality rate 
Deaths/person years 0.023 0.015 0.009 0.008 0.027 0.011 0.021 0.066
Multiple admission 
ANZPIC 
Diagnostic group  All groups CVS GI Injury Neuro Post op Resp Misc
Numbers of patients 779 342 89 15 63 15 163 92
PICU mortality n (%) 52 (6.7) 19 (5.6) 5 (5.6) 0 (0.0) 3 (4.8) 0 (0.0) 11 (6.7) 11 (12)
Mortality rate 
Deaths/person years 0.062 0.039 0.042 0.000 0.191 0.029 0.107 0.141
Mortality Rate Ratio  2.69 2.59 4.78 0.00 7.07 2.50 5.07 2.16
n=number of patients in group, MR=mortality rate (total number of deaths during time of 
follow-up, divided by total accumulated person-time during follow-up), expressed as deaths 
per person-years of follow-up time. MRR=mortality rate ratio (MR SADM / MR MADM).
SADM and MADM with and without CCC in subcategories
To conduct a more in-depth analysis of subgroups, the mortality in the different diagnos-
tic subgroups with and without CCC is presented in Tables 4 and 5 below.
  Patients with   Patients with    
  Multiple Admissions  a Single Admission  
 All  Deceased All  Deceased
Numbers of patients 272 27 (9.9%) 1,688 68 (4.0%)
Median age years (mean)*  0.5 (3.0) 0.4 (3.4) 0.4 (3.2) 1.3 (4.5)
Male sex (% of total) 172 (63%) 19 (11%) 1,156 (57.9%) 40 (3.6%)
ANZPIC diagnostic groups        
Cardiovascular 41 4 (9.7%) 319 12 (3.7%)
Respiratory 93 11 (11.8%) 412 15 (3.6%)
Miscellaneous 35 4 (11.4) 207 19 (9.2%)
Neurological 36 3 (8.3%) 252 11(4.3%)
Gastrointestinal/Renal 43 5 (11.6%) 226 5 (2.2%)
Postoperative 10 0 67 2 (3.0%)
Injury 14 0 205 4 (1.9%)
* Both median and mean age are presented to illustrate skewed distribution. 
Table 3. PICU mortality and mortality rate (MR) with mortality rate ratio (MRR) for single (SADM) 
and multiple (MADM) admissions groups, depending on admission diagnostic group.
Table 4. MADM and SADM patients without CCC and deaths in admission diagnostic groups. 
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 Patients with Multiple Patients with 
 Admissions and a a Single Admission and a  
 Complex Chronic Condition Complex Chronic Condition 
 All Deceased All Deceased
Number of patients 507 82 (16.2%) 1221 92 (7.5%)
Age years, median (mean)* 0.1 (1.6) 0.3 (2.4) 1.0 (3.5) 0.7 (3.3)
Male sex (% of total) 276 (54.4%) 40 (14.5%) 675 (55.3%) 53 (7.8%)
ANZPIC diagnostic groups    
Cardiovascular 302 30 (9.9%) 768 28 (3.6%)
Respiratory 69 18 (26.0%) 106 12 (11.3%)
Miscellaneous 56 23 (41.0%) 227 42 (18.5%)
Neurological 27 7 (25.9%) 60 9 (15.0%)
Gastrointestinal 47 4 (8.5%) 53 1 (1.9%)
Postoperative 5 1 (20%) 3 0
Injury 1 0 4 0
    
Complex Chronic Conditions
Subcategories  507 82 (16.2%) 1,221 92 (7.5%)
Age years, median (mean)* 0.1 (1.6) 0.3 (2.4) 1.0 (3.5) 0.7 (3.3)
Male sex 276 (54.4%) 40 (14.5%) 675 (5.5%) 53 (7.8%)
Cardiovascular 308 35 (11.4%) 761 29 (3.8%)
Respiratory 21 2 (9.5%) 47 4 (8.5%)
Neuromuscular 34 9 (26.4%) 82 12 (14.6%)
Congenital/genetic  44 6 (13.6%) 84 6 (7.1%)
Oncologic 40 19 (47.5%) 106 29 (25.5%)
Metabolic/endocrine 14 6 (42.8%) 88 8 (9.0%)
Renal 8 2 (25%) 12 1 (8.3%)
Gastrointestinal 24 1 (4.2%) 35 2 (5.7%)
Hematologic/immunologic 5 2 (40%) 3 1 (33.3%)
Miscellaneous** 0 0 3 0
* Both median and mean age are presented to illustrate skewed distribution. 
** Miscellaneous includes rheumatologic, orthopedic, and psychiatric conditions. 
Table 5. MADM and SADM patients with CCC and deaths in ANZPIC admission diagnostic 
groups and CCC subcategories.
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Readmission characteristics 
Among all admissions, there were 1,331 (26.5%) readmissions, of which 327 (24.6%) were 
readmissions within 48 hours from the previous discharge. The median time to readmis-
sion in this group was 22 hours (IQR: 8–28 hours), of which 1,004 (75.4%) readmissions 
occurred more than 48 hours after previous discharge with a median time of 48 days 
(IQR: 11–160 days). The rate of readmission, counting only early readmissions, was 6.5%. 
PICU readmission mortality was 6.4% (in 21 out of 327 readmissions) in this group and 
3.2% (in 31 of 1,004 readmissions) in the late readmission group. The median age was 3.4 
months (IQR: 0.5–20 months) in the early group and 8.5 months (IQR: 3.5–28 months) in 
the late group. In Swedish PICU facilities, (re)admissions are not classified as scheduled 
or unscheduled. Deaths among MADM patients—according to diagnostic group, early 
or late readmissions, PICU status, or final PICU stay—are presented in Table 10, page 32. 
Impact of having an increasing number of PICU admissions
When MADM patients were analyzed regarding number of PICU admissions, they dem-
onstrated between two and 14 admissions during the time of study. The majority of pa-
tients had two (64.3%) or three (20.5%) admissions. Only nine children in total had more 
than eight admissions. Details regarding presence of a CCC and mortality in the patients 
(depending on the number of admissions) are presented in Tables 6 and 7 below.
  
Number of admissions 2 3 4 5 6 7
Individuals n (%)* 501 (64.3) 160 (20.5) 55 (7.0) 32 (4.1) 9 (1.2) 7 (0.9)
Complex Chronic  
Condition n (%) 306 (61) 105 (65.6) 36 (65.5) 20 (62.5) 7 (77.8) 3 (42.9)
Deaths n (%) 61 (12.2) 20 (12.5) 10 (18.2) 9 (45) 2 (22.2) 2 (28.6)
Deaths with  
Complex Chronic  
Condition n (%) 41 (67.2) 15 (75) 6 (60) 5 (55.6) 1 (50) 0 
Number of admissions 8 9 10 11 12 13 14
Individuals n (%)* 6 (0.8) 3 (0.4) 2 (0.3) 1 (0.13) 1 (0.13) 1 (0.13) 1 (0.13)
Complex Chronic  
Condition n (%) 5 (83.3) 2 (66.7) 2 (100) 1 (100) 1 (100) 1 (100) 1 (100)
Deaths n (%) 2 (33.3) 1 (50) 0 1 (100) 1 (100) 0 1 (100)
Deaths with Complex 
Chronic Condition n (%)  1 (50) 0 0 1 (100) 1 (100) 0 1 (100)
n=number of individual patients, * (%) of 779 MADM individuals. 
Table 6. Number of admissions among the MADM patients and presence of CCC and death 
during the study. 2-7 admissions.
Table 7. Number of admissions among the MADM patients and presence of CCC and death 
during the study. 8-14 admissions.
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Transfer to PICU from other ICUs and units 
In total, 278 admissions to a PICU were documented as originating from an Adult Inten-
sive Care Unit (AICU) in another Swedish hospital, and 655 admissions occurred from 
another hospital. In the latter case, it was unclear if these transfers were a referral from 
an ICU, emergency room, or elsewhere. 
Age 0-16y 0-2d >2-28d >28d-24m >2-12y  >12-16y
median age 0.7y (260d) (0.9d) 9.6d 0.5y (168d) 5y 14.2y
All admissions  
(n=) 5019 304 754 2208 1353 400
Male/Female 56.8% / 43.2%          
PICU mortality  141 / 5,019  9  20/754  67/2,208 31/1,353 14 /400 
 (2.8%) (2.9%) (2.5%)  (3.0%) (2.3%) (3.5%)
LOS PICU  
median (days) 1.3d 3.3d 2.8d 1.55d 0.95d 0.92d
LOS PICU  
>3d days (%) 1412 159  340  614  232 66 
 (28.1%) (52.1%) (45.1%) (28.0%) (17.1%) (16.5%)
Table 8 Age groups, LOS, and PICU mortality
Admssion diagnositc group  
 Survival (%) No of  deaths Survival (%) No of  deaths p-value
  SADM  SADM MADM  MADM
Inj 98.1 0 100.0 4 0.6183
GI 97.8 9 89.7 6 0.0009
Post op 96.7 1 93.3 2 0.4181
CVS 96.4 31 90.7 40 >0.0001
Resp 94.9 27 81.1 26 >0.0001
Neuro 93.6 9 85.7 20 0.0437
Misc 86.1 26 71.0 59 0.0007
Table 9 table 2 P values for differences between groups presented in Fig 3
Diagnostic group CVS Misc Resp Neuro GI Inj Post Op
Readmission status (n=)           
Early (<48h), dead in PICU 8 5 4 3 1 0 0
Late (>48h), dead in PICU 11 9 7 0 4 0 0
Dead after PICU discharge 15 14 17 6 4 0 1
Table 10 Deaths among MADM patients — according to diagnostic group, early or late read-
missions, PICU status, or final PICU stay
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Paper III
We identified 1,793 consecutive admissions (1,255 patients) between newborn infants 
and 16 years of age. Of the 1,793 admissions, 990 had recorded information of PaO2 and 
FiO2. These 990 admissions formed the study group. 
The ratio females/males were 441/549 and 360/443 in the two groups with and without 
arterial blood gas data, respectively, p=0.9239.
Patients with PaO2 data available at admission were younger, 0.71 years (0.15 to 3.85 
years) and 1.51 years (0.27 to 6.48) for patients with and without PaO2 data, respectively, 
p<0.0001. The age difference between admission diagnostic groups was only statistically 
significant for the gastrointestinal group. The age distribution is presented in Table 11. 
  Age (years) 
 Admissions with  Admissions without 
 PaO2 Number PaO2 Number p-value
CVS 0.538 579 0.511 313 0.9337 
 (0.078 to 3.232)  (0.055 to 3.464)   
GI 0.421 101 2.025 92 0.0011 
 (0.062 to 2.546)  (0.269 to 8.562)   
Injur 6.717 20 9.715 38 0.6646 
 (3.154 to 15.35)  (3.324 to 14.06)   
Misc 1.684 116 3.147 129 0.561 
 (0.485 to 10.71)  (0.739 to 9.744)   
Neuro 2.672 32 2.688 79 0.9507 
 (0.974 to 7.11)  (0.988 to 8.476)   
Post Op 10.01 5 9.781 5 1.00000 
 (0.072 to 13.34)  (5.031 to 12.81)   
Resp 0.7143 137 1.335 147 0.1326 
 (0.214 to 4.418)  (0.262 to 4.839)   
All Admissions 0.7078 990 1.511 803 <0.0001 
 (0.149 to 3.853)  (0.273 to 6.485)
Table 11 Age distribution     
The numbers of admissions for the different diagnostic groups with and without PaO2 
values available on admission are presented in Table 12. 
Diagnoses with PaO2 without PaO2
 (n=990) (n=803)
CVS 579 313
GI 101 92
Injury 20 38
Misc 116 129
Neuro 32 79
Post Op   5 5
Resp 137 147
Table 12. The total number of admissions divided into diagnostic groups and admissions with 
and without PaO2 present at admission
The influence of arterial blood gas data on the estimation of the PIM2 score and probabil-
ity are presented in Figure 5A and 5B, respectively. 
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Figure 5A and 5B. Correlation between PIM2 scores and probability estimated with and without 
arterial blood gas data. Figure 5A shows the influence of arterial blood gas data on the estima-
tion of the PIM2 score. Percentage mean prediction error: –6.148%, percentage root mean 
square prediction error: 0.266%, Spearman rank correlation coefficient: 0.994.
Figure 5B shows the influence of arterial blood gas data on the estimation of probability. 
Percentage mean prediction error: 19.499%, percentage root mean square prediction error: 
3.055%, Spearman rank correlation coefficient: 0.994.
PIM2 score estimated with and without arterial blood gas data, as well as probability 
estimated with and without arterial blood gas data, were closely correlated (rs= 0.994 and 
0.994, respectively), with a percentage mean prediction error (MPE; bias) of –6.148% and 
19.499%, respectively and a percentage root mean square prediction error (RMSE; preci-
sion) of 0.266% and 3.055%, respectively. 
The influence of excluding arterial blood gas data for estimation of probability is 
illustrated for the non-respiratory and respiratory groups by plotting the probability, 
estimated from PIM2 omitting arterial blood gas data, versus PIM2 score estimated with 
arterial blood gas data, Figure 6A and 6B, respectively. 
Figure 6A and 6B. Probability, estimated from PIM2 omitting arterial blood gas data, versus 
PIM2 score estimated with arterial blood gas data.
Figure 6A shows data from patients in the non-respiratory group and Figure 6B shows data 
from the respiratory group(s). Solid lines show probability predicted for the PIM2 score with 
arterial blood gas data included. 
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In the non-respiratory group, we found a close agreement between predicted and 
true probability despite the fact that arterial blood gas data was omitted. For the respira-
tory group, important deviations of the predicted probability from the true probability 
occurred for PIM2 score exceeding –2.20 (probability > 10.0%). 
The difference in probability estimated from PIM2 scores with and without arterial 
blood gas data were larger in the respiratory group as compared to the non-respiratory 
group (p<0.0001). In patients with probability >10%, estimated without arterial blood gas 
data, the differences in probability with and without arterial blood gas data were 3.161 
(1.477 - 6.459) units in the non-respiratory group and 4.397 (2.802 - 9.251) in the respira-
tory group, respectively. The variability in the respiratory group was significantly larger 
(p<0.0001).
The SMR was slightly but not significantly overestimated by not including arterial 
blood gas data in the calculation of the PIM2 score, SMR for the two groups was 0.740 
(0.515-1.029) and 0.968 (0.591-1.495), respectively, Table 13.
 Admissions with PaO2/FiO2 ratio Admissions without 
 (Study Group) PaO2/FiO2 ratio
 All Resp Non-Resp 
 N=990 N=137 N=853 n=803
PIM2 estimated with   
PaO2/FiO2 ratio  
Number of death 35 7 28  
SMR
(95%CI) 0.606  0.554  0.621   
 (0.422 to 0.843) (0.222 to 1.142)  (0.413 to 0.897) 
PIM2 estimated  
without PaO2/FiO2 ratio       
Number of death 35 7 28 20  
SMR 0.740  0.770 0.733 0.968 
(95%CI) (0.515 to 1.029) (0.308 to 1.586) (0.487 to 1.059) (0.591 to 1.495)
p-value 0.4122 0.5099 0.5377 0.3073  
    (versus All without  
    PaO2/FiO2 ratio)
Table 13. Arterial blood gas data included respectively not included in the estimation of the 
PIM2 score and subsequent SMR. 
PIM2=paediatric index of mortality2, SMR= standardised mortality ratio, FiO2=fractional in-
spired oxygen, PaO2=arterial oxygen tension, Resp=respiratory, Non-Resp=non-respiratory
To examine the selection bias if the PaO2/FiO2 ratio was required for risk strati-
fication, we examined all 1,793 admissions, stratified by omitting the PaO2/FiO2 ratio 
from the PIM2 equation and its calculated probability. Patients with the PaO2/FiO2 ra-
tio available had a statistically significantly higher probability than patients without the 
PaO2/FiO2 ratio available at admission, 1.388 % (0.8361 - 4.049) and 0.7509% (0.4064-
2.179), respectively, p<0.0001. Data are presented in Table 14. 
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   Probability (%) 
 Admissions Number Admissions Number p-value
CVS 1.173 579 0.569 313 <0.0001
 (0.824 to 2.401)  (0.406 to 2.149)  
GI 1.317 101 0.598 92 <0.0001
 (0.717 to 2.596)  (0.271 to 1.364)  
Injur 4.240 20 0.829 38 0.0033
 (0.821 to 8.883)  (0.751 to 1.21)  
Misc 1.973 116 0.751 129 <0.0001
 (0.722 to 7.203)  (0.271 to 2.795)  
Neuro 4.030 32 1.022 79 <0.0001
 (1.400 to 8.157)  (0.751 to 2.795)  
Post Op 1.570 5 2.234 5 0.83400
 (1.081 to 2.991)  (1.16 to 10.04)  
Resp 3.312 137 0.751 147 <0.0001
 (1.054 to 8.444)  (0.4064 to 2.795)  
All Admissions 1.386 990 0.751 803 <0.0001
 (0.836 to 4.049)  (0.406 to 2.179)  
     
Table 14. Probability (%) was calculated from PIM2 estimated without PaO2 in both groups.
SMR for the two groups was 0.740 (0.515-1.029) and 0.968 (0.591-1.495), respectively, Table 13.
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Demographic data for the three groups presented in table 15 below.
Table 15
Deseaced  PICU Hosp Home
n= 145 71 36
cvs 43 21 6
GI 10 2 2
Misc 43 24 16
Neuro 17 7 3
Resp 27 15 9
post op other 1 2 0
Inj 4 0 0
LOS 7.7 8.1 2.8
Admissions 1.8 2.1 1.9
Age years 2.9 3.7 4.3
Male sex (%) 76 (52) 43 (61) 27 (75)
Demographic data, number of children in the three groups, deceased in; PICU, Hospital or 
at Home. CVS=Cardiovascular, GI=Gastrointestinal/Renal, Neuro=Neurological, Post Op= 
Postoperative, Resp= Respiratory, Inj= Injury and Misc= Miscellaneous. LOS= length of stay at 
first PICU admission, Age years= age at first PICU admission, Admissions=average number of 
admissions for the group during the time of the study.
Paper IV
Flow chart for the study
268 children died 
88 died in PICU 
on first admission
57 died in PICU 
on later admission
107 Place of death and LOMT status in medical notes
71 died in Hospital 
53 (75%) with LOMT limiting
PICU readmission
36 died at Home 
27 (75%) with LOMT limiting
PICU readmission
In children that died in PICU 
There was a LOMT in place
in 60 (41%) out of 145 children
Five of the children
died in an ER
With no LOMT 
limiting readmission to PICU
Ten of these children died
At home with no 
LOMT limiting
Readmission to PICU
123 (46%) died outside PICU
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Survival
A significant difference in survival was seen between the three groups. Presented below 
as Kaplan- Meier curves in fig. 7 and significant p-values in table 16.
 
 
Limitation Of Medical Treatment, LOMT and CCC.
There was a difference in numbers of LOMT limiting PICU readmission and presence of 
a complex chronic condition (CCC) in the groups. Presented in fig 8 below.
 
Figure 7 
Survival for the three 
groups over the time 
of the study. Place of 
death; red line PICU, 
yellow line in hospital, 
blue line at home.
Table 16
Significant difference  
between survival 
curves.
Fig 8. 
Presence of CCC and 
LOMT in the three 
groups respectively. 
Place of death; red 
colour PICU, yellow 
colour in hospital, blue 
colour at home.
Comparison of Survival Curves
Log-rank (Mantel-Cox) Test
Chi square 55,1
df 2
P value < 0.0001
P value summary ***
Are the survival curves sig different? Yes
Logrank test for trend
Chi square 31,59
df 1
P value < 0.0001
P value summary ***
Sig. trend? Yes
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Admission diagnostic panorama
There was no significant difference in PICU admission diagnostic panorama with regard 
to place of death. Although there was a trend through the three groups where the chil-
dren belonging to the CVS and Neuro were most present in the PICU with decreased 
numbers at home, while the groups Misc and Resp showed the reversed pattern of in-
creased numbers at home. Presented in fig 9 below.
 
Fig 9. Admission diagnostic groups for the three locations of death, in PICU, in hospital or at 
home.
Home group, no LOMT, characteristics
Of the children who died at home 9 had no LOMT recorded limiting readmission to 
PICU. Their mean age was 1.8 years, 5 (50%) had a CCC, 8 (80%) were males, admission 
diagnostic groups were; Resp 4, Misc 3, CVS 3.
Recorded causes of death were; sepsis 1, H1N1 infection 1, Sudden Infant death 1, cardiac 
abnormalities 3; (Transposition of the great arteries TGA 1, ventricular septal defect VSD 
1, Vitium Organis Cordis VOC unspecified 1), Bacterial pneumonia 1, RS infection 1, vi-
ral pneumonia 1, cerebral malformation 1. 
Another 5 children in the Hospital group died in an emergency room without any LOMT 
record limiting PICU readmission. 3 were males, CCC 4, CVS 3, Resp 2, recorded rea-
sons for death; left ventricular hypoplasia 1, pulmonary atresia 1, Vitium organis cordis, 
VOC unspecified 1, cerebral malformation and acute airway infection 1, respiratory in-
sufficiency 1. 
Lost to follow up
In the 17 children that were lost to follow up no clear place of death (n=10) and/or clear 
LOMT status confirming ‘yes’ or ‘no’ to PICU care (n=7) could be identified since re-
cords could not be accessed mainly due to technical reasons. There was a CCC present 
in 13 (76%) of the children and 10 (59%) were males. The disposition of admission diag-
nostic groups; Misc 5, Resp 5, CVS 4, Neuro 2 and G-I 1. Mean age was 2.3 years, which 
is slightly younger, and length of stay 9 days which is slightly longer than for the three 
groups PICU/Hospital/Home. 
40
6  DISCUSSION
At the outset of these studies, the need for ICU care for children in Sweden was not 
known and neither were prognostic factors for long-term outcomes after PICU discharge 
or the degree of LOMT at the end of life for the years after PICU care. In order to answer 
these questions, we had to create two nationwide cohorts and orchestrate a national co-
operation. We also asked ourselves if the most painful part of PIM2 -the arterial blood 
gas sampling could be limited without loss of accuracy. 
In Study I,16 we reported over 8,000 admissions made by over 6,600 children to 
AICUs (56%) and PICUs (44%) in Sweden. Noted, that children from 0-1months of age 
in PICUs and that children from 0-6 months in AICUs were not included in the cohort. 
Children treated in AICUs had very short LOS and most commonly (43%) had the ad-
mission diagnosis of  “injury”, largely due to concussion and alcohol intoxication. An ad-
mission diagnosis of post-operative and trauma had excellent long-term outcomes and 
miscellaneous had the poorest.
Today data from Study I can be compared with Study II and with updated admis-
sion data from the Swedish ICU-registry database as accessed online.17 Data for all chil-
dren admitted to intensive care from 2015 to 2017 demonstrate 10,893 admissions, where 
5,125 (53%) were to a PICU. PIM2 score was not recorded in the first cohort, but PICU 
and AICU mortality was low (2.5% and 1.9% respectively). PICU mortality reported in 
Study II was similar at 2.8%. These data seem to correspond with current outcome data 
from PICU and AICU at 3.0% and 1.5% respectively.17 
In Study I we also found a older average LOS and higher age, compared to published 
data.63-67 This could be caused by a higher turnover of PICU and AICU beds due to staff 
shortages, resulting in a pressure to discharge quickly. Age was obviously influenced by 
the fact that the youngest age groups (0-1 months in the PICU group and 0-6 months in 
the AICU group) were lacking in Study I. During this time, Sweden was 17th with re-
gards to PICU beds per 100,000 inhabitants among the European countries.68 Only five 
countries had fewer PICU beds per capita. The ICU admission rate of 1.59/1,000 children 
was slightly less than recent reports 63-66,69-70 but could be explained by the fact that the 
youngest children were not included in the cohort.
The survival curves from Study I and Study II display similar findings with regards 
to the diagnostic groups: miscellaneous had the poorest outcome, respiratory slowly con-
tinuously decreasing over the years’ after PICU discharge, and post op and injury pre-
sented no or single number of fatalities. An important finding in Study I was that the 
study cohort had a 20-fold increase in yearly mortality compared to the reference Swed-
ish population of the same age. 
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The data presented in Study I played an important role as a basis for discussion and 
judgement when the Swedish intensivists and professional societies met in 2013 and 
agreed on a national referral strategy: severely ill children should be transferred to a PICU 
as early as possible.71 The reported number of children being transferred to PICU from 
AICU increased from 65 in Study I to 278 in Study II and to 601 from 2015 to 2017.16, 17, 72 
The Swedish need for intensive care for children seem to slowly increase over the last 
20-years. Since the Swedish population did increase from 8.8 million in 1999 to 10.2 mil-
lion in 2018,73 there could be a true increase in numbers of PICU admissions in relation 
to this increased population.
Multiple admissions (MADM) and complex chronic conditions (CCC)
Through collected PIM2 data, in Study II we could confirm that Swedish PICU mortal-
ity was on par with published international data,74 and the same decrease in survival 
over time post PICU discharge was seen as in Study I (Fig 2-4 Study II). The PIM2 score 
had not yet been fully implemented into the Swedish AICU routines, so we could only 
focus on the PICU population. Both MADM75-77 and CCC58 had previously been associ-
ated with increased PICU mortality. We wanted to explore these factors’ impact on long-
term outcome. An important and original finding presented in Study II was that not only 
where MADM and CCC associated with poorer outcomes post PICU discharge. Like-
wise diagnostic groups presented very different mortality rate ratios (MRR) concern-
ing long-term outcomes. The impact of having a single admission (SADM), compared to 
multiple admissions (MADM) in combination with CCC resulted in differences in MRR 
from zero to seven times higher, depending on the admission diagnosis group. (Table 3 
Study II). Multiple hospital admissions have been shown in a retrospective cohort78 to be 
the most strongly associated factor with increased one-year mortality post hospital dis-
charge. However, the presented cohort of 700,000 children under 21 years of age included 
no observations of PICU care but suggested that MADM could be associated with poor 
long-term survival.
Early (<48h) vs late (>48h) readmissions have been extensively discussed in the lit-
erature as a possible marker of quality of care.75-77, 79-81 In Study II, we mainly focused on 
timeframes beyond this point but data on early and late readmissions are presented in ta-
ble 10. The concept of chronic critical illness (CCI), (defined as length of stay >28 days in 
PICU), has also attracted some attention,82 but under 2% of the patients in the cohort of 
Study II met the criteria. Therefore, we chose not to explore these data further.
PIM2 and arterial blood gas samples
To describe PIM2 was a key part of the data set of Study II. During the evaluation pro-
cess we were criticized by some reviewers and editors since in the cohort “only” 55% of 
the admissions could demonstrate PIM2 with an arterial blood gas. If this was because 
PIM2 requires an arterial blood gas to be complete, we beg to differ. When PIM2 was first 
launched, only approximately 39% of admissions had an arterial blood gas included.83 
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Thus, we set out to investigate (I) whether an arterial blood gas only is needed if clinically 
demanded, and (II) in which diagnostic group it is needed to maintain accuracy of mor-
tality prediction. To perform an arterial blood gas, the clinician often must inflict pain 
to the patient, and the process can be technically very difficult or even impossible in the 
acute care setting. We demonstrated that this step is only needed if clinically indicated 
and in patients belonging to the respiratory admission diagnosis group. With this infor-
mation we pose that no unnecessary arterial punctures should be performed on PICU 
admission, and a PIM2 (or PIM3) dataset can be evaluated for accuracy according to how 
many of the patients with respiratory admission diagnosis had an arterial blood gas per-
formed. 
Limitation of medical treatment (LOMT)
In Study II, we found that many of the children died outside the PICU after discharge. 
This bothered us. To determine if LOMT was the factor limiting PICU readmission when 
the children turned fatally ill, we designed a novel study addressing this question. We 
analyzed the deceased children from the Study II cohort according to place of death af-
ter discharge: in the PICU, in a hospital, or at home. Of the children who died within one 
to four years after being discharged from PICU, 46% died without being readmitted to 
PICU. Both the hospital group (66%) and the home group (34%) had 75% LOMT, which 
represents only a minimal numeral, as there may have been LOMTs decided at the bed-
side that were not noted into the patients medical record. Further, it could be argued that 
the concept of LOMT could be used to withhold PICU care from children. The present 
Swedish trend, on the contrary, is to give children the benefit of doubt when possible. In 
addition there are long-term PICUs (so called LIVAs) for children in need of home-ven-
tilator or other semi-chronic technical support. For example, children with severe neu-
rologic conditions, including a low degree of perceived awareness, often have a very poor 
or lack of ability to cough and swallow (e.g. in scoliosis that restricts lung function). This 
group of patients represents an example where ethical questions can be a big challenge 
for both the physician and the family. Should the patient have ventilatory support, tra-
cheostomy, and LIVA care for the rest of his/her life? The context of religion, cultural 
traditions and relatives involved can make these situations very difficult to manage. We 
perceive from our colleagues in Catholic European countries and from personal experi-
ence, that LOMT is often not a viable option and the end of a life in the PICU repeatedly 
involve legal conflicts.
It is worth reflecting on our finding that 75% of the children who die outside the 
PICU after discharge have a LOMT. Perhaps this should be 100%? According to the eth-
ical codes suggested by the main textbook in Swedish intensive care,3 intensive care 
should only be considered or performed if it can help the patient and cause no prolonged 
harm. If not, it should be withdrawn or not installed.
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The present findings come with some limitations 
In Study I, we did not have data on PIM2. In Study II, the children treated in AICU could 
not be focused on due to a lack of PIM2 data. The data evaluated originate from a single 
European country only (Sweden), which makes it problematic to judge external validity. 
If the database was 10 times larger, more precise conclusions could have been made. At 
present, some patient groups were small, and the presence of no or few individuals made 
statistical considerations problematic. However, this is an in-depth description and ex-
ploration of intensive care of Swedish children, so the narrow focus fulfills an initial goal 
of this thesis. 
There are some strength to this data
We formed two separate cohorts of all Swedish children admitted to PICU care with only 
5% lost to follow-up. The follow-up of the included children is close to 100%, thanks to 
the Swedish File of National Registration, which allowed us to collect mortality data on 
every deceased citizen. The two cohorts have been compared and were formed before and 
after a change in ICU-transfer policy. When first published, these data were unique and 
represented a basis for discussions regarding national policy changes.68
The presence of a sufficient number of available PICU beds is important, but even 
more important is the fact that the beds need to be staffed. Otherwise, the number of 
beds just represents a theoretical maximum capacity. 
PICU care is a complex system that demands full attention. According to the docu-
ment by the Swedish association of paediatric anaesthesia and paediatric intensive care, 
the “Svensk förening för barnanestesi och barnintensivvård” (SFBABI),68 multiple ad-
missions or readmission is a relative indication of transfer to PICU. Given the huge dif-
ference in MRR for different diagnostic groups some of the groups might always be con-
sidered for transfer. Some children at a certain stage of illness, where PICU care cannot 
affect the situation significantly, might eventually be more effectively managed in their 
local hospital. These decisions are delicate, and sound judgement by the clinician respon-
sible at the bedside is of supreme importance. 
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7  CONCLUSIONS
1.  Over the three years of the study (study 1, data 1998-2001) more than 8,000 admis-
sions were made by more than 6,600 children to Swedish intensive care. A large 
number (56%) of the children admitted to ICU receive care in an adult ICU (AICU).
2.  The Swedish PICU mortality and AICU mortality for these children were 2.5% and 
1.9% respectively.
3.  The long-term mortality (5-year) for the cohort was 7.3% (PICU) and 4.3% (AICU)  
respectively. There was an increased mortality (20 fold compared to the background  
population) for the whole cohort 5 years after discharge from PICU, although  
postoperative and injury patients showed no increase.
4.  Swedish PICU care (study 2, cohort and data 2008-2010 with more than 5,000 ad-
missions by 3,688 children) was on par with comparable countries and published 
outcome data.
5.  Children with multiple admissions (MADM) and complex chronic conditions (CCC) 
did significantly worse over time post PICU discharge, particularly in cases of both 
MADM and CCC (study 2). Different admission diagnostic groups carry very  
different increases in mortality risk after PICU discharge, spanning from 0- to 7-fold 
increase in mortality risk ratio (MRR).
6.  The ABG for PIM2 score should only be taken when clinically indicated or in  
children belonging to the respiratory admission diagnostic group.
7.  The children discharged from PICU, who were not readmitted when lethally ill, had 
a LOMT limiting PICU readmission in 75% of cases at the time of death.
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8  FUTURE PERSPECTIVES
On long-term outcome
Long-term outcome could and should be further explored. That would require a more de-
tailed data set reported to SIR. However, the ICD10 diagnosis that are acceptable to SIR 
need to be more developed and diverse to be able to more precise describe diagnoses in 
the pediatric population. The chosen ICD10 diagnosis could then automatically render 
an ANZPIC grouping at discharge confirmed by discharging clinician. Of note, still close 
to 50 % of children in need of ICU care in Sweden are treated in an adult ICU. There-
fore, all adult ICUs should be encouraged to report PIM3 score for all admitted children. 
Sweden has an advantage with the Cause of Death Register run by the National Board of 
Health and Welfare in Sweden, where long-term mortality can be assessed with very few 
patients lost-to-follow-up. 
It would be desirable to better understand which children should be centralized and 
which groups could safely remain having their treatment in an adult ICU. As Sweden is 
a large country with a vast and sparsely populated northern section, it is unlikely that 
PICU care will be made available everywhere. Transporting unstable patients over a long 
distance also add risks, which have to be taken into consideration. Consequently, the 
manifold issues related to centralization versus ‘stay-and-play’ will continue and need 
further work and study.
On reserve identification numbers
Some patients, who arrives through the emergency, are initially unidentified and will re-
ceive a “reserve identification number”, both physically (a plastic id-tag around the ankle) 
and noted into the medical journal. This number is generated locally at the admission 
hospital. Once the person is identified, the correct Swedish personal number will be used 
in the patients’ medical journal. Consequently, two journals with two different identifi-
cation numbers are created concerning the same patient. This obviously causes problems 
and insecurity at the actual care event, then again when a follow-up is planned. A more 
rational and secure way to do this would be if the reserve identification number were to 
be generated in one central computer, linked to the correct Swedish personal number. 
The patient would then have only one medical journal. This would certainly facilitate 
retrospective research and follow-up if organized on a national level for patient records. 
On mortality outcome monitoring
Mortality outcome monitoring (and PIM3) etc. can be supplemented by level of “intact 
discharge”. Thus, a parameter attempting to quantify morbidity at PICU discharge. It 
can be used to differentiate between children at risk for further problems and the risk of 
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death. Average level of morbidity measured on the discharged PICU patients need to be 
put in relation to the case mix in the PICU before evaluation is performed. Such a pa-
rameter has been used in congenital diaphragmatic hernia patients to evaluate the result 
of surgery and PICU care.84-85 It adds another quality to discharge monitoring than just 
an ICD10 diagnosis. 
On further exploration on the database
The database that was created for the second study contains a lot more than what has so 
far been published. Many different perspectives should be explored, such as need for hos-
pital care post ICU discharge, quality of life evaluations, school performance, and more. 
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